GSK PLC's ticker is and the CUSIP is 37733W204. A total of 880 filers reported holding GSK PLC in Q4 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,087 | -10.2% | 262 | 0.0% | 0.00% | 0.0% |
Q1 2024 | $11,232 | +18.3% | 262 | 0.0% | 0.00% | -33.3% |
Q4 2023 | $9,498 | -14.9% | 262 | -16.3% | 0.00% | 0.0% |
Q3 2023 | $11,155 | 0.0% | 313 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $11,155 | +175.0% | 313 | +174.6% | 0.00% | +200.0% |
Q1 2023 | $4,056 | -59.4% | 114 | -59.9% | 0.00% | -66.7% |
Q4 2022 | $9,980 | – | 284 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JTC Employer Solutions Trustee Ltd | 12,340,190 | $457,759 | 41.36% |
Eversept Partners, LP | 2,972,954 | $110,177,675 | 9.68% |
Soleus Capital Management, L.P. | 1,278,540 | $47,382,692 | 5.26% |
CANTOR FITZGERALD, L. P. | 638,657 | $23,668,628 | 4.86% |
Sio Capital Management, LLC | 571,391 | $21,175,750 | 4.82% |
Callodine Capital Management, LP | 450,000 | $16,677,000 | 4.39% |
EQUITY INVESTMENT CORP | 3,243,259 | $120,195,186 | 3.38% |
Clean Yield Group | 213,431 | $7,909,753 | 3.33% |
Robinson Value Management, Ltd. | 128,079 | $4,746,608 | 3.12% |
Hillman Capital Management, Inc. | 233,386 | $8,649,285 | 2.99% |